Cervical carcinoma
Conditions
Interventions
Experimental group:Interstitial brachytherapy, ISBT
Control group:Intracavitary brachytherapy
Sponsors
Chongqing University Three Gorges Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Patients with age > 18 years and = 7 points); (1) The standard of blood routine examination should meet: HB >= 90g / L; ANC >= 1.5 x 109 / L; PLT >= 60 x 10^9 / L; (2) Biochemical tests should meet the following criteria: ALB >= 29g / L; TBIL < 1.5 ' ULN; ALT and AST < 5 ' ULN; serum Cr <= 1.5 ' ULN; serum Cr <= 1.5 ' ULN; 8. Women of childbearing age must have a pregnancy test (serum or urine) within 7 days before enrollment, and the results are negative, and they are willing to use appropriate contraceptive methods during the trial and 8 weeks after the last treatment; 9. The subjects voluntarily joined the study, signed the informed consent form, and had good compliance and cooperated with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients in pregnancy or lactation period; 2. Patients with a history of other malignant tumors; 3. Patients with an estimated survival time of less than 3 months; 4. Patients with abnormal coagulation function (Pt or PT-INR > 1.5'ULN, APTT > 1.5'ULN) have bleeding tendency (such as active gastrointestinal ulcer); patients who are receiving thrombolytic or anticoagulant therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Countries
China
Contacts
Public ContactChang Shichuan
Chongqing University Three Gorges Hospital
Outcome results
None listed